Crown Aesthetics SkinPen Precision

Microneedling (non-RF) · Vertical-oscillation mechanical microneedling pen with sterile lockout cartridges

CurrentFDA status under reviewBe the first to review

What it's actually cleared for: Verified: FDA granted De Novo DEN160029 (2018, filed by Bellus Medical, now Crown) — the decision that created the microneedling-device regulation and made SkinPen the first FDA-cleared microneedling device, indicated for improving the appearance of facial acne scars in adults 22+. SkinPen Precision Elite received its own clearance in 2024; verify current labeling before advertising.

Last verified: August 6, 2026 · How we verify

New: $6k–$10k|Used: $1,500–$4kmarket estimate, no email required

Save device

Bottom line

The category king of plain (non-RF) microneedling and the highest-ROI device most medspas will ever buy: SkinPen Precision was the FIRST microneedling device the FDA ever cleared (De Novo, 2018), which Crown has weaponized in marketing against a sea of never-cleared gray-market pens. The device costs less than one month of a laser lease, cartridges run tens of dollars, and treatments retail at $300-600 — the margin math is almost embarrassing. Trade-offs are modest: results take a series, it won't tighten like RF microneedling, and Crown locks you into its cartridge ecosystem. Buy it early, keep it forever.

Overview

No editorial overview published for this platform yet.

How it works

The science

A cordless pen drives a sterile 14-needle cartridge in rapid vertical oscillation at adjustable depths (~0.25-2.5mm+), creating controlled micro-channels that trigger the wound-healing cascade — inflammation, proliferation, remodeling — and net new collagen and elastin. Cleared for facial acne scars (adults 22+) with subsequent clearance activity for neck wrinkles; in practice used across texture, fine lines, pores, and as the delivery step for PRP/PRF protocols (off-label). Three to six sessions at 4-6 week intervals; 1-3 days of redness. Safe across all Fitzpatrick types — a genuine advantage over light-based options.

Patented tech

The BioSleeve single-use cartridge system — a sterile barrier with fluid-ingress (backflow) protection and anti-reuse lockout — is the engineering moat and the reason it cleared FDA when competitors didn't; the disposable architecture doubles as Crown's razor-and-blades revenue model.

Origin

USA — designed and manufactured domestically for Crown Aesthetics (Crown Laboratories, Dallas, TX), marketed aggressively against imported pens.

FDA & regulatory status

FDA status under reviewRegulatory status not yet verified

What it's actually cleared for:

Verified: FDA granted De Novo DEN160029 (2018, filed by Bellus Medical, now Crown) — the decision that created the microneedling-device regulation and made SkinPen the first FDA-cleared microneedling device, indicated for improving the appearance of facial acne scars in adults 22+. SkinPen Precision Elite received its own clearance in 2024; verify current labeling before advertising.

Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.

Treatment economics

What practices charge

$250-600 per session (metro average ~$300-450 face), almost always in packages of 3 ($750-1,500) or memberships; PRP add-ons push tickets to $600-900. The classic "gateway" treatment that feeds patients into lasers and injectables.

Consumables & recurring cost

One sterile cartridge per treatment at roughly $40-60 through Crown (volume-tiered — verify), plus the hydrating serum kit. At 40 treatments/month that's ~$25-30k/year in consumables against ~$180k+ in revenue — the best consumable-to-revenue ratio in aesthetics.

Ideal for

Best-fit practice

Everyone from solo aesthetician-driven medspas (where state law allows) to derm offices — the default first device for a new practice and the workhorse add-on for established ones. Patients 25-55, all skin types, scar and texture concerns, budget tiers below laser resurfacing.

Compliance

Medical director & delegation

Class II device; who may perform microneedling varies sharply by state — some allow aestheticians under delegation at limited depths, others restrict to RN/NP/MD — map your state board's position before staffing it.

Contraindications & screening

Active acne flares/infection, keloid history, isotretinoin recency per policy, bleeding disorders/anticoagulants for deeper settings, pregnancy (practice policy), active cold sores without prophylaxis.

Ownership

Warranty & service

Simple, robust handpiece with ~1-year warranty and cheap replacement economics — service risk near zero compared with any laser; Crown's rep network doubles as clinical training support.

Resale & used market

Thin official resale — Crown ties cartridge accounts to authorized purchasers, which kneecaps gray-market pens ($1,500-4,000 when they trade); at this price point practices buy new and keep it.